Actively Recruiting
Led by AstraZeneca · Updated on 2026-04-30
625
Participants Needed
316
Research Sites
165 weeks
Total Duration
A
AstraZeneca
Lead Sponsor
D
Daiichi Sankyo
Collaborating Sponsor
Researchers are evaluating treatments for participants with PD-L1 positive locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC) in this Phase III, randomized, open-label, international study. The study aims to compare the effectiveness and safety of Datopotamab Deruxtecan (Dato-DXd) combined with durvalumab against investigator's choice chemotherapy combined with pembrolizumab, and also evaluates Dato-DXd alone. The main goal is to assess whether Dato-DXd with durvalumab helps participants live longer without their cancer worsening or improves overall survival compared to the standard chemotherapy plus pembrolizumab. Participants are assigned to one of three treatment groups: Dato-DXd combined with durvalumab; investigator's choice chemotherapy (paclitaxel, nab-paclitaxel, or gemcitabine plus carboplatin) combined with pembrolizumab; or Dato-DXd alone. All treatments are given by intravenous infusion. The study includes stratification by geographic location, disease-free interval history, and prior PD-1/PD-L1 treatment for early stage TNBC. Throughout the study, participants will undergo regular assessments including imaging to measure cancer progression, laboratory tests, and evaluations of symptoms and quality of life. Researchers will monitor progression-free survival, overall survival, response rates, duration of response, and time to deterioration in symptoms such as pain and physical functioning. Safety and tolerability of the treatments will also be closely observed. Participation may last up to several years with ongoing follow-up to capture long-term outcomes.
CONDITIONS
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 33 months or until disease progression or discontinuation
Participants receive treatment with either Dato-DXd with or without durvalumab, or investigator's choice of chemotherapy in combination with pembrolizumab, to assess effectiveness and safety in managing PD-L1 positive locally recurrent inoperable or metastatic triple-negative breast cancer.
Regular visits for treatment administration and monitoring as per protocol
Duration - Up to 31 months after treatment completion (up to 64 months total from randomization)
Participants are monitored for overall survival, subsequent therapies, and long-term safety after completing treatment.
Visits as scheduled for assessments and survival follow-up
Total: 316 locations
1
Research Site
Daphne, Alabama, United States, 36526
Actively Recruiting
2
Research Site
Springdale, Arkansas, United States, 72762
Actively Recruiting
3
Research Site
Duarte, California, United States, 91010
Withdrawn
4
Research Site
Glendale, California, United States, 91204
Actively Recruiting
5
Research Site
Sacramento, California, United States, 95817
Actively Recruiting
6
Research Site
Santa Rosa, California, United States, 95403
Withdrawn
7
Research Site
Aurora, Colorado, United States, 80012
Actively Recruiting
8
Research Site
New Haven, Connecticut, United States, 06510
Actively Recruiting
9
Research Site
Jacksonville, Florida, United States, 32256
Withdrawn
10
Research Site
Miami, Florida, United States, 33176
Actively Recruiting
11
Research Site
Palm Bay, Florida, United States, 32909
Withdrawn
12
Research Site
Plantation, Florida, United States, 33324
Actively Recruiting
13
Research Site
Atlanta, Georgia, United States, 30318
Suspended
14
Research Site
Honolulu, Hawaii, United States, 96819
Withdrawn
15
Research Site
Chicago, Illinois, United States, 60637
Actively Recruiting
16
Research Site
Decatur, Illinois, United States, 62526
Withdrawn
17
Research Site
Elmhurst, Illinois, United States, 60126
Withdrawn
18
Research Site
Naperville, Illinois, United States, 60540
Withdrawn
19
Research Site
New Albany, Indiana, United States, 47150
Withdrawn
20
Research Site
Des Moines, Iowa, United States, 50309
Actively Recruiting
21
Research Site
Lexington, Kentucky, United States, 40503
Withdrawn
22
Research Site
Louisville, Kentucky, United States, 40202
Withdrawn
23
Research Site
Louisville, Kentucky, United States, 40207
Withdrawn
24
Research Site
Baton Rouge, Louisiana, United States, 70808
Withdrawn
25
Research Site
Baton Rouge, Louisiana, United States, 70809
Actively Recruiting
26
Research Site
Baltimore, Maryland, United States, 21215
Withdrawn
27
Research Site
Columbia, Maryland, United States, 21044
Actively Recruiting
28
Research Site
Boston, Massachusetts, United States, 02111
Withdrawn
29
Research Site
Worcester, Massachusetts, United States, 01655
Withdrawn
30
Research Site
Detroit, Michigan, United States, 48201
Actively Recruiting
31
Research Site
Grand Rapids, Michigan, United States, 49503
Withdrawn
32
Research Site
Saint Paul, Minnesota, United States, 55109
Actively Recruiting
33
Research Site
Hattiesburg, Mississippi, United States, 39401
Withdrawn
34
Research Site
St Louis, Missouri, United States, 63129
Actively Recruiting
35
Research Site
Albuquerque, New Mexico, United States, 87109
Actively Recruiting
36
Research Site
Albany, New York, United States, 12206
Withdrawn
37
Research Site
New York, New York, United States, 10065
Actively Recruiting
38
Research Site
Stony Brook, New York, United States, 11794-7263
Actively Recruiting
39
Research Site
Cincinnati, Ohio, United States, 45219
Actively Recruiting
40
Research Site
Cincinnati, Ohio, United States, 45245
Actively Recruiting
41
Research Site
Cleveland, Ohio, United States, 44195
Actively Recruiting
42
Research Site
York, Pennsylvania, United States, 17403
Withdrawn
43
Research Site
Providence, Rhode Island, United States, 02903
Actively Recruiting
44
Research Site
Chattanooga, Tennessee, United States, 37404
Actively Recruiting
45
Research Site
Nashville, Tennessee, United States, 37203
Actively Recruiting
46
Research Site
Dallas, Texas, United States, 75230
Withdrawn
47
Research Site
Dallas, Texas, United States, 75246
Actively Recruiting
48
Research Site
Dallas, Texas, United States, 75246
Withdrawn
49
Research Site
El Paso, Texas, United States, 79902
Actively Recruiting
50
Research Site
Flower Mound, Texas, United States, 75028
Withdrawn
51
Research Site
Fort Worth, Texas, United States, 76104
Withdrawn
52
Research Site
Houston, Texas, United States, 77054
Withdrawn
53
Research Site
Houston, Texas, United States, 77090
Withdrawn
54
Research Site
Houston, Texas, United States, 77098
Withdrawn
55
Research Site
Kingwood, Texas, United States, 77339
Withdrawn
56
Research Site
McKinney, Texas, United States, 75071
Withdrawn
57
Research Site
Sugar Land, Texas, United States, 77479
Actively Recruiting
58
Research Site
Charlottesville, Virginia, United States, 22903
Actively Recruiting
59
Research Site
Fairfax, Virginia, United States, 22031
Actively Recruiting
60
Research Site
Midlothian, Virginia, United States, 23114
Actively Recruiting
61
Research Site
Norfolk, Virginia, United States, 23502
Actively Recruiting
62
Research Site
Roanoke, Virginia, United States, 24014
Actively Recruiting
63
Research Site
Tacoma, Washington, United States, 98405
Actively Recruiting
64
Research Site
Madison, Wisconsin, United States, 53792
Withdrawn
65
Research Site
CABA, Argentina, 1414
Actively Recruiting
66
Research Site
CABA, Argentina, 1425
Actively Recruiting
67
Research Site
CABA, Argentina, C1113AAE
Actively Recruiting
68
Research Site
CABA, Argentina, C1425
Withdrawn
69
Research Site
Ciudad Autónoma Buenos Aires, Argentina, C1430EFA
Actively Recruiting
70
Research Site
Ciudad de Buenos Aires, Argentina, C1015ABO
Actively Recruiting
71
Research Site
Rosario, Argentina, 2000
Actively Recruiting
72
Research Site
San Nicolás de los Arroyos, Argentina, B2900
Withdrawn
73
Research Site
Camperdown, Australia, 2050
Actively Recruiting
74
Research Site
Darlinghurst, Australia, 2010
Completed
75
Research Site
Heidelberg, Australia, 3084
Completed
76
Research Site
Melbourne, Australia, 3000
Actively Recruiting
77
Research Site
Nedlands, Australia, 6009
Actively Recruiting
78
Research Site
Waratah, Australia, 2298
Withdrawn
79
Research Site
Barretos, Brazil, 14784-400
Actively Recruiting
80
Research Site
Curitiba, Brazil, 80730-150
Actively Recruiting
81
Research Site
Florianópolis, Brazil, 88034-000
Actively Recruiting
82
Research Site
Goiânia, Brazil, 74000-000
Actively Recruiting
83
Research Site
Itajaí, Brazil, 88301-220
Actively Recruiting
84
Research Site
Porto Alegre, Brazil, 90035-003
Actively Recruiting
85
Research Site
Recife, Brazil, 52010-075
Actively Recruiting
86
Research Site
São Paulo, Brazil, 01246-000
Actively Recruiting
87
Research Site
São Paulo, Brazil, 01317-001
Actively Recruiting
88
Research Site
Teresina, Brazil, 64049-200
Actively Recruiting
89
Research Site
Barrie, Ontario, Canada, L4M 6M2
Actively Recruiting
90
Research Site
Hamilton, Ontario, Canada, L8V 5C2
Actively Recruiting
91
Research Site
Toronto, Ontario, Canada, M5G 2M9
Actively Recruiting
92
Research Site
Greenfield Park, Quebec, Canada, J4V 2H1
Actively Recruiting
93
Research Site
Montreal, Quebec, Canada, H2X 0A9
Actively Recruiting
94
Research Site
Montreal, Quebec, Canada, H4A 3J1
Actively Recruiting
95
Research Site
Québec, Quebec, Canada, G1S 4L8
Actively Recruiting
96
Research Site
Regina, Saskatchewan, Canada, S4T 7T1
Actively Recruiting
97
Research Site
Saskatoon, Saskatchewan, Canada, S7N 4H4
Actively Recruiting
98
Research Site
Anyang, China, 455000
Actively Recruiting
99
Research Site
Beijing, China, 100044
Actively Recruiting
100
Research Site
Beijing, China, 100142
Actively Recruiting
101
Research Site
Bengbu, China, 233004
Actively Recruiting
102
Research Site
Changchun, China, 130021
Actively Recruiting
103
Research Site
Changsha, China, 410008
Actively Recruiting
104
Research Site
Changsha, China, 410013
Actively Recruiting
105
Research Site
Chengdu, China, 610000
Actively Recruiting
106
Research Site
Chengdu, China, 610041
Actively Recruiting
107
Research Site
Chongqing, China, 400030
Withdrawn
108
Research Site
Fuzhou, China, 350014
Actively Recruiting
109
Research Site
Guangzhou, China, 510060
Actively Recruiting
110
Research Site
Guangzhou, China, 510120
Actively Recruiting
111
Research Site
Guangzhou, China, 510700
Actively Recruiting
112
Research Site
Hangzhou, China, 310009
Actively Recruiting
113
Research Site
Hangzhou, China, 310016
Actively Recruiting
114
Research Site
Hangzhou, China, 310022
Actively Recruiting
115
Research Site
Harbin, China, 150081
Actively Recruiting
116
Research Site
Hefei, China, 230031
Actively Recruiting
117
Research Site
Jinan, China, 250021
Actively Recruiting
118
Research Site
Meizhou, China, 514031
Not Yet Recruiting
119
Research Site
Nanchang, China, 330009
Actively Recruiting
120
Research Site
Nanjing, China, 2100008
Actively Recruiting
121
Research Site
Nanjing, China, 210009
Actively Recruiting
122
Research Site
Nanning, China, 530021
Actively Recruiting
123
Research Site
Shandong, China
Actively Recruiting
124
Research Site
Shanghai, China, 200025
Actively Recruiting
125
Research Site
Shanghai, China, 200080
Completed
126
Research Site
Shenyang, China, 110004
Actively Recruiting
127
Research Site
Tianjin, China, 300000
Actively Recruiting
128
Research Site
Wenzhou, China, 325000
Actively Recruiting
129
Research Site
Wuhan, China, 430022
Actively Recruiting
130
Research Site
Wuhan, China, 430079
Actively Recruiting
131
Research Site
Xi'an, China, 710061
Actively Recruiting
132
Research Site
Xiamen, China, 361003
Actively Recruiting
133
Research Site
Xintai, China, 54031
Actively Recruiting
134
Research Site
Xuzhou, China, 221009
Actively Recruiting
135
Research Site
Zhanjiang, China, 524003
Actively Recruiting
136
Research Site
Zhengzhou, China, 450008
Actively Recruiting
137
Research Site
Zhengzhou, China, 450052
Actively Recruiting
138
Research Site
Lille, France, 59000
Actively Recruiting
139
Research Site
Lyon, France, 69373
Actively Recruiting
140
Research Site
Montpellier, France, 34298
Actively Recruiting
141
Research Site
Paris, France, 75020
Actively Recruiting
142
Research Site
Saint-Herblain, France, 44805
Actively Recruiting
143
Research Site
Toulouse, France, 31059
Actively Recruiting
144
Research Site
Vandœuvre-lès-Nancy, France, 54511
Actively Recruiting
145
Research Site
Villejuif, France, 94800
Actively Recruiting
146
Research Site
Düsseldorf, Germany, 40479
Withdrawn
147
Research Site
Essen, Germany, 45136
Withdrawn
148
Research Site
Georgsmarienhütte, Germany, 49124
Withdrawn
149
Research Site
Hamburg, Germany, 20357
Withdrawn
150
Research Site
Hanover, Germany, 30625
Withdrawn
151
Research Site
Heidelberg, Germany, 69120
Withdrawn
152
Research Site
Heilbronn, Germany, 74078
Withdrawn
153
Research Site
Leipzig, Germany, 04103
Withdrawn
154
Research Site
Hong Kong, Hong Kong, 999077
Actively Recruiting
155
Research Site
Hong Kong, Hong Kong, 999077
Not Yet Recruiting
156
Research Site
Hong Kong, Hong Kong
Actively Recruiting
157
Research Site
Shatin, Hong Kong, 00000
Actively Recruiting
158
Research Site
Calicut, India, 673601
Withdrawn
159
Research Site
Chennai, India, 600031
Actively Recruiting
160
Research Site
Jaipur, India, 302004
Not Yet Recruiting
161
Research Site
Kochi, India, 682027
Withdrawn
162
Research Site
Kolkata, India, 700160
Withdrawn
163
Research Site
Marg Jaipur, India, 302004
Actively Recruiting
164
Research Site
Mohali, India, 160055
Actively Recruiting
165
Research Site
Mysuru, India, 570017
Actively Recruiting
166
Research Site
Nagpur, India, 440001
Actively Recruiting
167
Research Site
Nashik, India, 422009
Actively Recruiting
168
Research Site
New Delhi, India, 110075
Actively Recruiting
169
Research Site
New Delhi, India, 11029
Actively Recruiting
170
Research Site
Puducherry, India, 605006
Actively Recruiting
171
Research Site
Surat, India, 395002
Actively Recruiting
172
Research Site
Thiruvananthapuram, India, 695011
Actively Recruiting
173
Research Site
Vadodara, India, 391760
Actively Recruiting
174
Research Site
Visakhapatnam, India, 530053
Withdrawn
175
Research Site
Bergamo, Italy, 24127
Actively Recruiting
176
Research Site
Empoli, Italy, 50053
Actively Recruiting
177
Research Site
Milan, Italy, 20132
Actively Recruiting
178
Research Site
Milan, Italy, 20141
Actively Recruiting
179
Research Site
Modena, Italy, 41124
Withdrawn
180
Research Site
Naples, Italy, 80131
Actively Recruiting
181
Research Site
Padova, Italy, 35128
Actively Recruiting
182
Research Site
Reggio Emilia, Italy, 42123
Actively Recruiting
183
Research Site
Roma, Italy, 00168
Actively Recruiting
184
Research Site
Rozzano, Italy, 20089
Actively Recruiting
185
Research Site
Akashi-shi, Japan, 673-8558
Actively Recruiting
186
Research Site
Bunkyō City, Japan, 113-8431
Actively Recruiting
187
Research Site
Bunkyō City, Japan, 113-8677
Actively Recruiting
188
Research Site
Chiba, Japan, 260-8717
Actively Recruiting
189
Research Site
Chūōku, Japan, 104-0045
Actively Recruiting
190
Research Site
Fukuoka, Japan, 811-1395
Actively Recruiting
191
Research Site
Fukushima, Japan, 960-1295
Actively Recruiting
192
Research Site
Gifu, Japan, 501-1194
Actively Recruiting
193
Research Site
Hidaka-shi, Japan, 350-1298
Actively Recruiting
194
Research Site
Hiroshima, Japan, 730-8518
Actively Recruiting
195
Research Site
Hiroshima, Japan, 734-8551
Actively Recruiting
196
Research Site
Isehara-shi, Japan, 259-1193
Actively Recruiting
197
Research Site
Kamogawa-shi, Japan, 296-8602
Actively Recruiting
198
Research Site
Kashiwa, Japan, 277-8577
Actively Recruiting
199
Research Site
Kitaadachi-gun, Japan, 362-0806
Actively Recruiting
200
Research Site
Kōtoku, Japan, 135-8550
Actively Recruiting
201
Research Site
Kumamoto, Japan, 860-8556
Actively Recruiting
202
Research Site
Kurume-shi, Japan, 830-0011
Actively Recruiting
203
Research Site
Matsuyama, Japan, 791-0280
Actively Recruiting
204
Research Site
Nagoya, Japan, 466-8560
Actively Recruiting
205
Research Site
Nagoya, Japan, 467-8602
Actively Recruiting
206
Research Site
Niigata, Japan, 951-8566
Actively Recruiting
207
Research Site
Nishinomiya-shi, Japan, 663-8501
Actively Recruiting
208
Research Site
Okayama, Japan, 700-8558
Actively Recruiting
209
Research Site
Osaka, Japan, 541-8567
Actively Recruiting
210
Research Site
Osakasayama-shi, Japan, 589-8511
Actively Recruiting
211
Research Site
Ota-shi, Japan, 373-8550
Actively Recruiting
212
Research Site
Sapporo, Japan, 003-0804
Actively Recruiting
213
Research Site
Sendai, Japan, 980-8574
Actively Recruiting
214
Research Site
Shinagawa-ku, Japan, 142-8666
Actively Recruiting
215
Research Site
Shinjuku-ku, Japan, 160-0023
Actively Recruiting
216
Research Site
Shinjuku-ku, Japan, 162-8655
Actively Recruiting
217
Research Site
Tsu, Japan, 514-8507
Actively Recruiting
218
Research Site
Tsukuba, Japan, 305-8577
Actively Recruiting
219
Research Site
Yokohama, Japan, 241-8515
Actively Recruiting
220
Research Site
CD Mexico, Mexico, 04980
Actively Recruiting
221
Research Site
Guadalajara, Mexico, 44638
Actively Recruiting
222
Research Site
Guadalajara, Mexico, 44670
Withdrawn
223
Research Site
Mexico City, Mexico, 0 3100
Actively Recruiting
224
Research Site
México, Mexico, 04700
Actively Recruiting
225
Research Site
México, Mexico, 6760
Actively Recruiting
226
Research Site
Tuxtla Gutiérrez, Mexico, 29090
Actively Recruiting
227
Research Site
Bacolod, Philippines, 6100
Actively Recruiting
228
Research Site
Cebu City, Philippines, 6000
Actively Recruiting
229
Research Site
City of Muntinlupa, Philippines, 1780
Actively Recruiting
230
Research Site
Manila, Philippines, 1000
Actively Recruiting
231
Research Site
Quezon City, Philippines, 1112
Actively Recruiting
232
Research Site
San Juan City, Philippines, 1502
Actively Recruiting
233
Research Site
Bialystok, Poland, 15-027
Withdrawn
234
Research Site
Bydgoszcz, Poland, 85-796
Withdrawn
235
Research Site
Gdansk, Poland, 80-952
Actively Recruiting
236
Research Site
Gdynia, Poland, 81-519
Withdrawn
237
Research Site
Konin, Poland, 62-500
Withdrawn
238
Research Site
Krakow, Poland, 31-115
Withdrawn
239
Research Site
Krakow, Poland, 31-501
Actively Recruiting
240
Research Site
Legnica, Poland, 59-220
Withdrawn
241
Research Site
Lodz, Poland, 90-302
Actively Recruiting
242
Research Site
Lublin, Poland, 20-090
Withdrawn
243
Research Site
Przemyśl, Poland, 37-700
Withdrawn
244
Research Site
Warsaw, Poland, 02-781
Actively Recruiting
245
Research Site
Wroclaw, Poland, 53-413
Withdrawn
246
Research Site
Singapore, Singapore, 119228
Withdrawn
247
Research Site
Singapore, Singapore, 169610
Actively Recruiting
248
Research Site
Singapore, Singapore, 217562
Actively Recruiting
249
Research Site
Singapore, Singapore, 308433
Actively Recruiting
250
Research Site
Cape Town, South Africa, 7570
Actively Recruiting
251
Research Site
Johannesburg, South Africa, 2013
Actively Recruiting
252
Research Site
Johannesburg, South Africa, 2193
Actively Recruiting
253
Research Site
Johannesburg, South Africa, 2196
Actively Recruiting
254
Research Site
Paarl, South Africa, 7646
Actively Recruiting
255
Research Site
Pretoria, South Africa, 0081
Active, Not Recruiting
256
Research Site
Pretoria, South Africa, 0081
Actively Recruiting
257
Research Site
Busan, South Korea, 49241
Completed
258
Research Site
Daegu, South Korea, 41404
Actively Recruiting
259
Research Site
Goyang-si, South Korea, 10408
Actively Recruiting
260
Research Site
Seongnam-si, South Korea, 13620
Actively Recruiting
261
Research Site
Seoul, South Korea, 02841
Actively Recruiting
262
Research Site
Seoul, South Korea, 03080
Actively Recruiting
263
Research Site
Seoul, South Korea, 03722
Actively Recruiting
264
Research Site
Seoul, South Korea, 05505
Actively Recruiting
265
Research Site
Seoul, South Korea, 06273
Actively Recruiting
266
Research Site
Seoul, South Korea, 06351
Actively Recruiting
267
Research Site
Seoul, South Korea, 06591
Actively Recruiting
268
Research Site
Barcelona, Spain, 08028
Withdrawn
269
Research Site
Barcelona, Spain, 8035
Actively Recruiting
270
Research Site
Granada, Spain, 18016
Actively Recruiting
271
Research Site
Hospitalet deLlobregat, Spain, 08907
Actively Recruiting
272
Research Site
Madrid, Spain, 28007
Actively Recruiting
273
Research Site
Madrid, Spain, 28034
Withdrawn
274
Research Site
Pamplona, Spain, 31008
Actively Recruiting
275
Research Site
Santander, Spain, 39008
Actively Recruiting
276
Research Site
Hsinchu, Taiwan, 300
Actively Recruiting
277
Research Site
Kaohsiung City, Taiwan, 80756
Actively Recruiting
278
Research Site
Taichung, Taiwan, 40447
Actively Recruiting
279
Research Site
Tainan, Taiwan, 704
Actively Recruiting
280
Research Site
Taipei, Taiwan, 100
Actively Recruiting
281
Research Site
Taipei, Taiwan, 10449
Actively Recruiting
282
Research Site
Taipei, Taiwan, 11259
Actively Recruiting
283
Research Site
Taipei, Taiwan, 112
Actively Recruiting
284
Research Site
Taoyuan, Taiwan, 333
Actively Recruiting
285
Research Site
Bangkok, Thailand, 10210
Actively Recruiting
286
Research Site
Bangkok, Thailand, 10330
Actively Recruiting
287
Research Site
Bangkok, Thailand, 10400
Actively Recruiting
288
Research Site
Bangkok, Thailand, 10700
Not Yet Recruiting
289
Research Site
Chiang Mai, Thailand, 50200
Actively Recruiting
290
Research Site
Dusit, Thailand, 10300
Actively Recruiting
291
Research Site
Khon Kaen, Thailand, 40002
Actively Recruiting
292
Research Site
Songkhla, Thailand, 90110
Actively Recruiting
293
Research Site
Ankara, Turkey (Türkiye), 06520
Actively Recruiting
294
Research Site
Ankara, Turkey (Türkiye), 6200
Actively Recruiting
295
Research Site
Besevler Ankara, Turkey (Türkiye)
Actively Recruiting
296
Research Site
Istanbul, Turkey (Türkiye), 34010
Actively Recruiting
297
Research Site
Izmir, Turkey (Türkiye), 35575
Withdrawn
298
Research Site
Küçükçekmece, Turkey (Türkiye), 34295
Actively Recruiting
299
Research Site
Samsun, Turkey (Türkiye), 55200
Actively Recruiting
300
Research Site
Cardiff, United Kingdom, CF14 2TL
Actively Recruiting
301
Research Site
Chelsea, United Kingdom, SW3 6JJ
Actively Recruiting
302
Research Site
Leicester, United Kingdom, Le5 4PW
Actively Recruiting
303
Research Site
Liverpool, United Kingdom, L7 8YA
Terminated
304
Research Site
London, United Kingdom, EC1A 7BE
Actively Recruiting
305
Research Site
London, United Kingdom, SW17 0QT
Withdrawn
306
Research Site
Oxford, United Kingdom, OX3 7LE
Suspended
307
Research Site
Surrey, United Kingdom, GU2 7XX
Suspended
308
Research Site
Sutton, United Kingdom, SM2 5PT
Actively Recruiting
309
Research Site
Taunton, United Kingdom, TA1 5DA
Actively Recruiting
310
Research Site
Da Nang, Vietnam, 550000
Actively Recruiting
311
Research Site
Hanoi, Vietnam, 100000
Actively Recruiting
312
Research Site
Ho Chi Minh City, Vietnam, 700000
Actively Recruiting
313
Research Site
Hồ Chí Minh, Vietnam, 700000
Actively Recruiting
314
Research Site
Huế, Vietnam, 530000
Actively Recruiting
315
Research Site
Viet Tri, Vietnam, 35000
Actively Recruiting
316
Research Site
Vinh, Vietnam, 460000
Actively Recruiting
A
AstraZeneca Clinical Study Information Center
A
AstraZeneca Breast Cancer Study Locator Service
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Peter Schmid, Mafalda Oliveira, Joyce O'Shaughnessy...
https://pubmed.ncbi.nlm.nih.gov/40297626